GeneDx Holdings Corp.
WGS
$98.01
$0.740.76%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 94.20M | 77.42M | 69.44M | 61.10M | 55.21M |
| Total Other Revenue | 1.44M | -544.00K | 1.08M | 1.32M | 2.20M |
| Total Revenue | 95.64M | 76.87M | 70.51M | 62.42M | 57.42M |
| Cost of Revenue | 29.44M | 29.04M | 27.56M | 24.96M | 26.66M |
| Gross Profit | 66.21M | 47.84M | 42.95M | 37.46M | 30.75M |
| SG&A Expenses | 43.48M | 43.17M | 41.76M | 38.53M | 38.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 785.00K | 774.00K | 874.00K | 974.00K | 687.00K |
| Total Operating Expenses | 85.14M | 84.65M | 81.09M | 76.03M | 75.39M |
| Operating Income | 10.50M | -7.77M | -10.58M | -13.61M | -17.97M |
| Income Before Tax | 5.41M | -8.36M | -29.36M | -20.32M | -26.18M |
| Income Tax Expenses | -24.00K | -47.00K | -190.00K | -82.00K | -411.00K |
| Earnings from Continuing Operations | 5.44M | -8.31M | -29.17M | -20.24M | -25.77M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 5.44M | -8.31M | -29.17M | -20.24M | -25.77M |
| EBIT | 10.50M | -7.77M | -10.58M | -13.61M | -17.97M |
| EBITDA | 15.16M | -1.85M | -5.36M | -8.36M | -8.08M |
| EPS Basic | 0.20 | -0.31 | -1.10 | -0.78 | -0.99 |
| Normalized Basic EPS | 0.45 | -0.19 | -0.69 | -0.49 | -0.40 |
| EPS Diluted | 0.20 | -0.31 | -1.10 | -0.78 | -0.99 |
| Normalized Diluted EPS | 0.45 | -0.19 | -0.69 | -0.49 | -0.40 |
| Average Basic Shares Outstanding | 27.78M | 27.10M | 26.62M | 26.06M | 25.92M |
| Average Diluted Shares Outstanding | 27.78M | 27.10M | 26.62M | 26.06M | 25.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
